Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ReneSola Ltd. (SOL): Hedge Fund Sentiment Unchanged

Is ReneSola Ltd. (NYSE:SOL) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 payment structure, hedge funds have more incentives and resources than the average investor. The funds have access to expert networks and get tips from industry insiders. They also employ numerous Ivy League graduates and MBAs. Like everyone else, hedge funds perform miserably at times, but their consensus picks have historically outperformed the market after risk adjustments.

ReneSola Ltd. (NYSE:SOL) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 2 hedge funds’ portfolios at the end of September. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Summit Therapeutics PLC (NASDAQ:SMMT), Kopin Corporation (NASDAQ:KOPN), and Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) to gather more data points. Our calculations also showed that SOL isn’t among the 30 most popular stocks among hedge funds (see the video below).
5 Most Popular Stocks Among Hedge Funds
Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the Russell 2000 ETFs by 40 percentage points since May 2014 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 27.8% through November 21, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

RENAISSANCE TECHNOLOGIES

Jim Simons of RENAISSANCE TECHNOLOGIES

We’re going to take a look at the fresh hedge fund action surrounding ReneSola Ltd. (NYSE:SOL).

How have hedgies been trading ReneSola Ltd. (NYSE:SOL)?

Heading into the fourth quarter of 2019, a total of 2 of the hedge funds tracked by Insider Monkey were long this stock, a change of 0% from the second quarter of 2019. By comparison, 2 hedge funds held shares or bullish call options in SOL a year ago. With hedge funds’ sentiment swirling, there exists a few notable hedge fund managers who were upping their stakes meaningfully (or already accumulated large positions).

SOL_nov2019

According to Insider Monkey’s hedge fund database, Himanshu H. Shah’s Shah Capital Management has the most valuable position in ReneSola Ltd. (NYSE:SOL), worth close to $5.7 million, comprising 3.1% of its total 13F portfolio. The second most bullish fund manager is Renaissance Technologies founded by Jim Simons, with a $1.2 million position; less than 0.1%% of its 13F portfolio is allocated to the company.

Earlier we told you that the aggregate hedge fund interest in the stock was unchanged and we view this as a negative development. Even though there weren’t any hedge funds dumping their holdings during the third quarter, there weren’t any hedge funds initiating brand new positions. This indicates that hedge funds, at the very best, perceive this stock as dead money and they haven’t identified any viable catalysts that can attract investor attention.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as ReneSola Ltd. (NYSE:SOL) but similarly valued. These stocks are Summit Therapeutics PLC (NASDAQ:SMMT), Kopin Corporation (NASDAQ:KOPN), Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), and Motus GI Holdings, Inc. (NASDAQ:MOTS). This group of stocks’ market valuations resemble SOL’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
SMMT 3 3596 0
KOPN 7 3232 4
SBPH 8 13851 1
MOTS 10 13588 1
Average 7 8567 1.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 7 hedge funds with bullish positions and the average amount invested in these stocks was $9 million. That figure was $7 million in SOL’s case. Motus GI Holdings, Inc. (NASDAQ:MOTS) is the most popular stock in this table. On the other hand Summit Therapeutics PLC (NASDAQ:SMMT) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks ReneSola Ltd. (NYSE:SOL) is even less popular than SMMT. Our calculations showed that top 20 most popular stocks among hedge funds returned 34.7% in 2019 through November 22nd and outperformed the S&P 500 ETF (SPY) by 8.5 percentage points. A small number of hedge funds were also right about betting on SOL, though not to the same extent, as the stock returned 7.4% during the fourth quarter (through 11/22) and outperformed the market as well.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.